#China #Cancer Treatment #Foshan #RayStation #Heyou Hospital

Heyou Hospital's Landmark Selection of RayStation

RaySearch Laboratories AB (publ) proudly announces its collaboration with Heyou Hospital, located in Foshan City, Guangdong Province, China. This partnership represents a monumental step in advancing cancer treatment as the hospital has placed an order for the RayStation ® treatment planning system. Valued at RMB 51 million (approximately SEK 77 million), this order marks the third largest in RaySearch's history and signals a significant milestone since December 2022.

Heyou Hospital is distinguished for its commitment to providing personalized healthcare and conducting high-quality research, particularly in oncology, neurology, orthopedics, and neurosurgery. In 2021, the hospital enhanced its capabilities by acquiring a combined Hitachi carbon ion and proton therapy system. The recent order for RayStation will further augment this investment by enabling advanced treatment planning for both its carbon ion and conventional photon treatment systems.

Ion beam therapy represents the pinnacle of external radiotherapy. It employs protons or carbon ions to target tumors with unmatched precision. This precision in energy deposition allows for a marked reduction in radiation exposure to healthy tissue, thus minimizing the side effects often associated with conventional photon-based therapies. The growing adoption of particle treatments in China places RaySearch in a leading position, further solidified by this substantial order from Heyou Hospital.

The integration of the RayStation system will allow the hospital to leverage groundbreaking technologies, including pencil beam scanning, robust optimization methods, and linear energy transfer optimization—methods designed to enhance treatment effectiveness and patient outcomes. Additionally, advanced features such as GPU-accelerated dose calculations and adaptive replanning support will be pivotal in personalizing patient care.

Johan Löf, the founder and CEO of RaySearch, expressed his enthusiasm about this collaboration: "I am thrilled to announce our partnership with Heyou Hospital and the significant order for RayStation. We look forward to nurturing our relationship and ensuring fruitful cooperation in the realm of advanced radiation therapy."

Heyou Hospital's commitment to pioneering healthcare solutions, paired with RaySearch’s innovative technology, positions both entities at the forefront of cancer treatment advancements. As the market for particle treatments continues to expand in China, collaborations like this pave the way for more effective, tailored treatment modalities that can significantly enhance patient health and recovery.

With this partnership, Heyou Hospital is poised to make a transformative impact on cancer treatment practices, reinforcing its status as a world-class medical institution. As treatment options evolve, both the hospital and RaySearch remain dedicated to their shared mission: improving patient outcomes and pioneering advancements in cancer therapies. Through this landmark order, the journey towards more effective and precision-based treatment methodologies is set to begin, with great promise for future healthcare landscapes in China.

For more information regarding RaySearch Laboratories and its advanced treatment solutions, please reach out to the contact provided in the collaboration announcement.